The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMobeus I&g 2 Regulatory News (MIG)

Share Price Information for Mobeus I&g 2 (MIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 59.00
Bid: 57.50
Ask: 60.50
Change: 0.00 (0.00%)
Spread: 3.00 (5.217%)
Open: 59.00
High: 59.00
Low: 59.00
Prev. Close: 59.00
MIG Live PriceLast checked at -
Mobeus Income & Growth 2 VCT is an Investment Trust

To provide investors with a regular income stream, arising both from the income generated by companies selected for the portfolio and from realising any growth in capital, while continuing at all times to qualify as a VCT.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

9 Feb 2016 17:02

RNS Number : 5771O
Mobeus Income & Growth 2 VCT PLC
09 February 2016
 

Mobeus Income & Growth 2 VCT plc

(the "Company")

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 31 December 2015

 

Mobeus Income & Growth 2 VCT plc presents an Interim Management Statement for the quarter ended 31 December 2015. The statement also includes relevant financial information between the end of the quarter and the date of this statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

 

 

At 31 December 2015

At 30 September 2015

 

Net assets attributable to shareholders

£44,749,017

£43,980,781

Shares in issue

36,218,463

36,218,463

Net asset value (NAV) per share

123.55p

121.43p

Cumulative dividends paid to date per share

42.00p

42.00p

Total return per share since inception (NAV basis)

165.55p

163.43p

 

DIVIDENDS

 

No dividends were paid during the quarter.

 

The Board has today declared an interim dividend of 5.00 pence per share for the year ending 31 March 2016, which will be paid on 18 March 2016 to shareholders on the share register on 19 February 2016. This dividend fulfils the Company's target of paying a dividend in respect of each financial year of not less than 5.00 pence per share, as stated in the Annual Report and Accounts for the year ended 31 March 2015.

 

SHARE BUY-BACKS

 

There were no share buy-backs during the quarter.

 

INVESTMENT ACTIVITY

 

New Investments

 

On 2 October 2015, amounts held in existing companies preparing to trade, Knighton Management Limited (£0.89 million) and Tovey Management Limited (£0.85 million), were used to invest in Access IS Limited, a leading provider of data capture and scanning hardware. A further non-qualifying loan of £0.22 million was made to Access IS Limited.

 

A follow-on loan investment was also made into Racoon International of £0.05 million, on 7 October 2015.

 

Realisations

 

On 2 December 2015, the Company realised its investment in Tessella Holdings Limited.

 

The Company received £2.10 million from the sale and realised a gain over cost of £1.39 million. As part of the transaction, the Company has retained a small investment in Preservica, a data archiving business previously held within Tessella. Total cash proceeds received over the life of this investment are £2.55 million and represent a multiple of 2.8 times the original cost of this investment of £0.91 million.

 

During January 2016, a total of £0.17 million was received as deferred consideration from previous disposals of Monsal Holdings, Focus Pharma Holdings, Youngman Group and ATG Media Holdings.

 

Loan Stock Repayments

 

A total of £0.23 million was received in loan stock repayments and premiums during the quarter to 31 December 2015, from Jablite, Leap New Co (Ward Thomas), and Fullfield (Motorclean).

 

After the quarter end, a further £0.66 million in loan stock repayments and premiums was received from Leap New Co (Ward Thomas) and Fullfield (Motorclean).

REGULATORY DEVELOPMENTS

 

In the Half-Yearly Report to shareholders dated 26 November 2015, the Board informed shareholders of its intended response to the new legislation contained in the UK Finance Act 2015, which had become law on 18 November 2015. In summary, the new rules are designed to ensure that VCT investment is used only for growth and development purposes. Investments by VCTs to finance the acquisitions of businesses, such as MBO investments, are no longer permitted. The Board stated that it would draft a revised Investment Policy which it would invite shareholders to approve at or before the next annual general meeting.

 

Since the Half-Yearly Report, the Board has continued to work with the Investment Adviser and other professional advisers to understand the full implications of the new rules for the Investment Policy. At this juncture, the Board sees no reason to amend its response, as outlined above and more fully in the Half-Yearly Report. Alongside this process, the Investment Adviser is focusing upon investment opportunities that comply with the new legislation.

 

 

 

Please note that all of the information above is unaudited.

 

Other than as described above, there were no material events during the quarter and to the date of this announcement.

 

 

For further information, please contact:

Jonathan McGuire, for Mobeus Equity Partners LLP, Company Secretary: 020 7024 7600

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSQKLFBQLFEBBK
Date   Source Headline
1st May 20247:00 amRNSTotal Voting Rights and Capital
2nd Apr 20249:30 amRNSTotal Voting Rights and Capital
28th Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Mar 202410:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Mar 202411:00 amRNSTotal Voting Rights and Capital
28th Feb 20243:30 pmRNSMerger Discussions
27th Feb 20242:00 pmRNSRealisation of Investment: Master Removers Group
21st Feb 20247:00 amRNSInterim Management Statement
20th Feb 20243:00 pmRNSDividend Declaration
1st Feb 202411:42 amRNSVoting Rights and Capital
23rd Jan 202412:45 pmRNSDirector Declaration - Non-Executive Appointment
22nd Jan 20242:00 pmRNSTransaction in Own Shares and Total Voting Rights
2nd Jan 20241:00 pmRNSVoting Rights and Capital
21st Dec 202310:00 amRNSTransaction in Own Shares
1st Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20237:00 amRNSINTERIM RESULTS TO 30 SEPTEMBER 2023
1st Nov 20237:00 amRNSTotal Voting Rights
12th Oct 20237:00 amRNSStatement re Change of Registrar
2nd Oct 20237:00 amRNSTotal Voting Rights
27th Sep 20231:00 pmRNSTransaction in Own Shares
13th Sep 202312:15 pmRNSResult of AGM
13th Sep 202311:46 amRNSDividend Declaration - Replacement
13th Sep 202310:00 amRNSDividend Declaration
12th Sep 202310:30 amRNSInterim Management Statement
1st Sep 20237:00 amRNSTotal Voting Rights
1st Aug 20237:00 amRNSTotal Voting Rights
26th Jul 20232:30 pmRNSInvestment Adviser Co-investment Incentive Scheme
19th Jul 20233:00 pmRNSTransaction in Own Shares
13th Jul 20237:00 amRNSAnnual Financial Report
3rd Jul 20237:00 amRNSTotal Voting Rights
1st Jun 20237:00 amRNSTotal Voting Rights
2nd May 202310:00 amRNSTotal Voting Rights
3rd Apr 20237:00 amRNSTotal Voting Rights
29th Mar 202310:00 amRNSTransaction in Own Shares
27th Mar 20231:00 pmRNSRealisation of investment: Tharstern Group Limited
7th Mar 20237:30 amRNSTransaction in Own Shares
1st Mar 20237:00 amRNSTotal Voting Rights
22nd Feb 20233:32 pmRNSDividend Declaration
7th Feb 20235:00 pmRNSInterim Management Statement
6th Feb 20235:25 pmRNSIssue of Equity and Total Voting Rights
1st Feb 20237:00 amRNSTotal Voting Rights
31st Jan 202311:07 amRNSIssue of Supplementary Prospectus
27th Jan 20232:00 pmRNSNet Asset Value(s)
16th Jan 20237:00 amRNSCHANGE OF ALLOTMENT DATE
11th Jan 20235:35 pmRNSTransaction in Own Shares
15th Dec 20229:36 amRNSINTERIM RESULTS TO 30 SEPTEMBER 2022
5th Dec 20224:00 pmRNSPartial realisation of investment - EOTH Limited
16th Nov 20225:52 pmRNSIssue of Equity and Total Voting Rights
8th Nov 20225:42 pmRNSTHE OFFER FOR SUBSCRIPTION IS NOW FULLY SUBSCRIBED
4th Nov 20229:50 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.